Atlas Trials

Longbio Pharma

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Longbio Pharma

RecordFirmDate
Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease (NCT07363265)Longbio Pharma2026-02-02
A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (NCT07313917)Longbio Pharma2026-01-20
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT07266155)Longbio Pharma2025-12-05
A Study of Single Dose of LP-003 in Adolescent Subjects (NCT07148557)Longbio Pharma2025-10-01
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients (NCT07342803)Longbio Pharma2025-01-25
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. (NCT07212426)Longbio Pharma2024-11-14
A Study of Single Dose of LP-003 in Healthy Adult Subjects (NCT06604949)Longbio Pharma2024-10-23
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis (NCT07291284)Longbio Pharma2024-08-01
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment (NCT06228560)Longbio Pharma2024-01-26
A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants (NCT06294301)Longbio Pharma2023-11-23
Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult (NCT06046391)Longbio Pharma2023-07-06
A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects (NCT06294275)Longbio Pharma2022-09-03
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants (NCT06294288)Longbio Pharma2022-07-13

Track Longbio Pharma automatically

Every clearance here is in the API, with alerts when new ones post.